EARTHY

Subcutaneous biosimilar medications for patient self-administration

COMMERCIAL BRAND
EARTHY

ACTIVE PRINCIPLE
TERIPARATIDE

TYPE OF DEVICE
INJECTABLE SOLUTION

LATEX
DO NOT

TEMPERING TIME
-

START OF INJECTION
Inserting the needle into the skin

CLICK TO THE START (IN PEN)
DO NOT

CLICK AT THE END (IN PEN)
DO NOT

BioSim Newsletter

Subscribe to receive a weekly summary of current events on biosimilar medicines in your email.

SUBSCRIBE